Found: 2

Select item for more details and to access through your institution.

  • The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.

    Published in:
    Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 5, p. 350, doi. 10.1111/jcpt.12077
    By:
    • Cangoz, S.;
    • Chang, Y.‐Y.;
    • Chempakaseril, S. J.;
    • Guduru, R. C.;
    • Huynh, L. M.;
    • John, J. S.;
    • John, S. T.;
    • Joseph, M. E.;
    • Judge, R.;
    • Kimmey, R.;
    • Kudratov, K.;
    • Lee, P. J.;
    • Madhani, I. C.;
    • Shim, P. J.;
    • Singh, S.;
    • Ruchalski, C.;
    • Raffa, R. B.
    Publication type:
    Article

  • Vitamin D and type 2 diabetes mellitus.

    Published in:
    Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 2, p. 81, doi. 10.1111/jcpt.12026
    By:
    • Cangoz, S.;
    • Chang, Y.‐Y.;
    • Chempakaseril, S. J.;
    • Guduru, R. C.;
    • Huynh, L. M.;
    • John, J. S.;
    • John, S. T.;
    • Joseph, M. E.;
    • Judge, R.;
    • Kimmey, R.;
    • Kudratov, K.;
    • Lee, P. J.;
    • Madhani, I. C.;
    • Shim, P. J.;
    • Singh, S.;
    • Ruchalski, C.;
    • Raffa, R. B.
    Publication type:
    Article